Peptide-Based Hematological Disorders Therapeutics Market to Grow at 8.1% CAGR, Reaching US$ 1,253.9 Million by 2034
Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeutics, says Fact.MR. ROCKVILLE , MD, UNITED STATES, December 13, 2024 /EINPresswire.com/ -- According to Fact.MR, a …